Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Pyroptosis, a type of programmed cell death (PCD), is characterized by cell swelling with bubbles, and the release of inflammatory cell cytokines. Cucurbitacin B (CuB), extracted from muskmelon pedicel, is a natural bioactive product that could effectively exert anti-tumor activities in lung cancer. However, the exact molecular mechanisms and the direct targets of CuB in non-small cell lung cancer (NSCLC) remain to be discovered. Here, we firstly found that CuB exerted an anti-tumor effect via pyroptosis in NSCLC cells and NSCLC mice models. Next, based on the molecular docking and cellular thermal shift assay (CETSA), we identified that CuB directly bound to Toll-like receptor 4 (TLR4) to activate the NLRP3 inflammasome, which further caused the separation of N- and C-terminals of Gasdermin D (GSDMD) to execute pyroptosis. Moreover, CuB enhanced the mitochondrial reactive oxygen species (ROS), mitochondrial membrane protein Tom20 accumulation, and cytosolic calcium (Ca2+) release, leading to pyroptosis in NSCLC cells. Silencing of TLR4 inhibited CuB-induced pyroptosis and decreased the level of ROS and Ca2+ in A549 cells. In vivo study showed that CuB treatment suppressed lung tumor growth in mice via pyroptosis without dose-dependent manner, and CuB at 0.75 mg/kg had a better anti-tumor effect compared to the Gefitinib group. Taken together, our findings revealed the mechanisms and targets of CuB triggering pyroptosis in NSCLC, thus supporting the notion of developing CuB as a promising therapeutic agent for NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Activation of apoptosis signalling pathways by reactive oxygen species
Redza-Dutordoir, M., & Averill-Bates, D. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.012 · Cited by 3,731
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,183
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Gasdermins: Effectors of Pyroptosis
Kovacs, S. B., & Miao, E. A. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.005 · Cited by 1,379
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
He, Y., Zeng, M. Y., Yang, D., Motro, B., & Núñez, G. (2016) · Nature · doi:10.1038/nature16959 · Cited by 1,295
Pyroptosis: A new frontier in cancer
Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., Yu, T., Wu, X., Shi, Y., Ma, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109595 · Cited by 1,049
Self-citationThe role of pyroptosis in cancer: pro-cancer or pro-“host”?
Xia, X., Wang, X., Cheng, Z., Qin, W., Lei, L., Jiang, J., & Hu, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1883-8 · Cited by 856
Cell death-based treatment of lung adenocarcinoma
Denisenko, T. V., Budkevich, I. N., & Zhivotovsky, B. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0063-y · Cited by 768
ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation
Rühl, S., Shkarina, K., Demarco, B., Heilig, R., Santos, J. C., & Broz, P. (2018) · Science · doi:10.1126/science.aar7607 · Cited by 742
Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis
Zhou, B., Zhang, J.-Y., Liu, X.-S., Chen, H.-Z., Ai, Y.-L., Cheng, K., Sun, R.-Y., Zhou, D., Han, J., & Wu, Q. (2018) · Cell Research · doi:10.1038/s41422-018-0090-y · Cited by 660
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Toll-like receptors activation, signaling, and targeting: an overview
El-Zayat, S. R., Sibaii, H., & Mannaa, F. A. (2019) · Bulletin of the National Research Centre · doi:10.1186/s42269-019-0227-2 · Cited by 556
Sher, T., Dy, G. K., & Adjei, A. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.355 · Cited by 498
Karmakar, M., Minns, M., Greenberg, E. N., Diaz-Aponte, J., Pestonjamasp, K., Johnson, J. L., Rathkey, J. K., Abbott, D. W., Wang, K., Shao, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16043-9 · Cited by 450
Chen, X., Liu, G., Yuan, Y., Wu, G., Wang, S., & Yuan, L. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2157-1 · Cited by 388
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
de Vasconcelos, N. M., Van Opdenbosch, N., Van Gorp, H., Parthoens, E., & Lamkanfi, M. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0106-7 · Cited by 369
Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation
Wang, Y., Shi, P., Chen, Q., Huang, Z., Zou, D., Zhang, J., Gao, X., & Lin, Z. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz020 · Cited by 362
Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana
Jayaprakasam, B., Seeram, N. P., & Nair, M. G. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00497-4 · Cited by 291
Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
Martín-Sánchez, F., Diamond, C., Zeitler, M., Gomez, A. I., Baroja-Mazo, A., Bagnall, J., Spiller, D., White, M., Daniels, M. J. D., Mortellaro, A., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.176 · Cited by 279
Jia, C., Zhang, J., Chen, H., Zhuge, Y., Chen, H., Qian, F., Zhou, K., Niu, C., Wang, F., Qiu, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2021-3 · Cited by 275
Cucurbitacins - An insight into medicinal leads from nature
Aeri, V., Kaushik, U., & Mir, S. (2015) · Pharmacognosy Reviews · doi:10.4103/0973-7847.156314 · Cited by 252
Thoennissen, N. H., Iwanski, G. B., Doan, N. B., Okamoto, R., Lin, P., Abbassi, S., Song, J. H., Yin, D., Toh, M., Xie, W. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0536 · Cited by 234
Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
Ottewell, P. D., Monkkonen, H., Jones, M., Lefley, D. V., Coleman, R. E., & Holen, I. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn240 · Cited by 225
Yang, Y., Liu, P. Y., Bao, W., Chen, S. J., Wu, F. S., & Zhu, P. Y. (2020) · BMC Cancer · doi:10.1186/s12885-019-6491-6 · Cited by 203
GSDMD is required for effector CD8+ T cell responses to lung cancer cells
Xi, G., Gao, J., Wan, B., Zhan, P., Xu, W., Lv, T., & Song, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105713 · Cited by 177
TLR4/NF-κB Signaling Induces GSDMD-Related Pyroptosis in Tubular Cells in Diabetic Kidney Disease
Wang, Y., Zhu, X., Yuan, S., Wen, S., Liu, X., Wang, C., Qu, Z., Li, J., Liu, H., Sun, L., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00603 · Cited by 177
Xu, S., Wang, J., Jiang, J., Song, J., Zhu, W., Zhang, F., Shao, M., Xu, H., Ma, X., & Lyu, F. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02824-z · Cited by 171
Modulation of Protein-Interaction States through the Cell Cycle
Dai, L., Zhao, T., Bisteau, X., Sun, W., Prabhu, N., Lim, Y. T., Sobota, R. M., Kaldis, P., & Nordlund, P. (2018) · Cell · doi:10.1016/j.cell.2018.03.065 · Cited by 168
Franco-Iborra, S., Cuadros, T., Parent, A., Romero‐Giménez, J., Vila, M., & Perier, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1154-0 · Cited by 150
Complement pathway amplifies caspase-11–dependent cell death and endotoxin-induced sepsis severity
Napier, B. A., Brubaker, S. W., Sweeney, T. E., Monette, P., Rothmeier, G. H., Gertsvolf, N. A., Puschnik, A., Carette, J. E., Khatri, P., & Monack, D. M. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160027 · Cited by 149
p53 regulates a non-apoptotic death induced by ROS
Montero, J., Dutta, C., van Bodegom, D., Weinstock, D. M., & Letai, A. G. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.52 · Cited by 138
Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis
Wang, F., Liu, W., Ning, J., Wang, J., Lang, Y., Jin, X., Zhu, K., Wang, X., Li, X., Yang, F., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23542 · Cited by 136
Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review)
Garg, S., Kaul, S. C., & Wadhwa, R. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4203 · Cited by 123
Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
Prathumsap, N., Shinlapawittayatorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172818 · Cited by 118
Wu, X., Ren, G., Zhou, R., Ge, J., & Chen, F. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0135-3 · Cited by 95
Dubois, H., Sorgeloos, F., Sarvestani, S. T., Martens, L., Saeys, Y., Mackenzie, J. M., Lamkanfi, M., Loo, G., Goodfellow, I., & Wullaert, A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007709 · Cited by 94
Jabaut, J., Ather, J. L., Taracanova, A., Poynter, M. E., & Ckless, K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.025 · Cited by 89
Iwanski, G. B., Lee, D. H., Ein-Gal, S. Y., Doan, N., Castor, B., Vogt, M., Toh, M., Bokemeyer, C., SAID, J. W., Thoennissen, N. H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00741.x · Cited by 79
Kausar, H., Munagala, R., Bansal, S. S., Aqil, F., Vadhanam, M. V., & Gupta, R. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.008 · Cited by 75
Wei, M., Li, Z., Xiao, L., & Yang, Z. R. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.09.002 · Cited by 69
ZHANG, M., Bian, Z., ZHANG, Y., Wang, J., Kan, L., WANG, X., Niu, H., & HE, P. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2581 · Cited by 65
Shukla, S., Khan, S. U., Kumar, S., Sinha, S., Farhan, M., Bora, H. K., Maurya, R., & Meeran, S. M. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0286 · Cited by 64
Mouasni, S., Gonzalez, V., Schmitt, A., Bennana, E., Guillonneau, F., Mistou, S., Avouac, J., Ea, H., Devauchelle‐Pensec, V., Gottenberg, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1412-9 · Cited by 60
Liu, X., Duan, C., Ji, J., Zhang, T., Yuan, X., Zhang, Y., Ma, W., Yang, J., Yang, L., Jiang, Z., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5648 · Cited by 58
Liu, P., Xiang, Y., Liu, X., Zhang, T., Yang, R., Chen, S., Xu, L., Yu, Q., Zhao, H., Zhang, L., et al. (2019) · Molecules · doi:10.3390/molecules24030647 · Cited by 58
Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages
Kim, M.-J., Park, S. Y., JIN, M. L., Park, G., & Son, H. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1085065 · Cited by 40
Defying Death: The (W)hole Truth about the Fate of GSDMD Pores
Evavold, C. L., & Kagan, J. C. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.032 · Cited by 38
Garg, S., Huifu, H., Kumari, A., Sundar, D., Kaul, S. C., & Wadhwa, R. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz077 · Cited by 38
Cucurbitacin‐B attenuates CC l4‐induced hepatic fibrosis in mice through inhibition of STAT‐3
Sallam, A. M., Esmat, A., & Abdel‐Naim, A. B. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13160 · Cited by 37
Naggar, E. M. B. E., Chalupová, M., Pražanová, G., Parák, T., Švajdlenka, E., Žemlička, M., & Suchý, P. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2015.06.012 · Cited by 35
Protective Effects of Cucurbitacin B on Acute Lung Injury Induced by Sepsis in Rats
Hua, S., Liu, X., Lv, S., & Wang, Z. (2017) · Medical Science Monitor · doi:10.12659/msm.900523 · Cited by 35
Eltom, S. M., Belvisi, M. G., Yew‐Booth, L., Dekkak, B., Maher, S. A., Dubuis, E. D., Jones, V. M., Fitzgerald, K. A., & Birrell, M. A. (2014) · Respiratory Research · doi:10.1186/s12931-014-0087-0 · Cited by 34
Zhdanov, A. V., Ward, M. W., Taylor, C. T., Souslova, E. A., Chudakov, D. M., Prehn, J. H. M., & Papkovsky, D. B. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.06.006 · Cited by 33
Cho, J. H., You, Y.-M., Yeom, Y. I., Lee, D. C., Kim, B., Won, M., Cho, B. C., Kang, M., Park, S., Yang, S.-J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0651-5 · Cited by 32
Self-citationEffect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer
Zhang, Q., Li, R., Xu, C., Lee, S. B., Pan, J., Xiong, D., Hu, J., Miller, M. S., Szabo, E. M., Lubet, R. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19785 · Cited by 31
Lee, M.-S., Kim, H., Kim, T.-Y., & Lee, S. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.017 · Cited by 30
Yabuta, S., & Shidoji, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20194118 · Cited by 29
Cited by
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Metadata
- Authors
- Yuan, R., Zhao, W., Wang, Q.-Q., He, J., Han, S., Gao, H., Feng, Y., & Yang, S.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 170
- Pages
- 105748
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W3183008954
- Cited by
- 265
- References
- 61
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.